IDEAS home Printed from https://ideas.repec.org/p/hal/journl/hal-03889400.html
   My bibliography  Save this paper

The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis

Author

Listed:
  • Anne‐sophie Michallet
  • Stephanie Malartre
  • Elodie Vignaud
  • Alexiane Bocquet
  • Pascale Sontag
  • Christelle Galvez
  • Jean‐yves Blay
  • Pierre Heudel
  • Alexandre Vimont
  • Martin Blachier
  • Marie Ferrua
  • Olivier Mir
  • Etienne Minvielle

    (i3-CRG - Centre de recherche en gestion i3 - X - École polytechnique - Université Paris-Saclay - I3 - Institut interdisciplinaire de l’innovation - CNRS - Centre National de la Recherche Scientifique)

Abstract

Context: The need for patient navigator is growing, and there is a lack of cost evaluation, especially during survivorship. Objective: The objective of this study is to evaluate the cost-effectiveness of an Ambulatory Medical Assistance (AMA) programme in patients with haematological malignancies (HM). Design: A cost-effectiveness analysis of the AMA programme was performed compared to a simulated control arm. Setting: An interventional, single-arm and prospective study was conducted in a French reference haematology–oncology centre between 2016 and 2020. Participants: Adult patients were enrolled with histologically documented malignant haematology, during their active therapy phase, and treated either by intravenous chemotherapy or oral therapy. Methods: An extrapolation of the effectiveness was derived from a similar nurse monitoring programme (CAPRI study). Cost effectiveness of the programme was evaluated through adverse events of Grade 3 or 4 avoided in different populations. Results: Included patient (n=797) from the AMA programme were followed during125 days (IQR: 0–181), and adverse events (Grade 3/4) were observed in 10.1% of patients versus 13.4% in the simulated control arm. The overall cost of AE avoided was estimated to€81,113, leading to an ICER of€864. Conclusion: The AMA programme was shown to be cost-effective compared to a simulated control arm with no intervention

Suggested Citation

  • Anne‐sophie Michallet & Stephanie Malartre & Elodie Vignaud & Alexiane Bocquet & Pascale Sontag & Christelle Galvez & Jean‐yves Blay & Pierre Heudel & Alexandre Vimont & Martin Blachier & Marie Ferrua, 2022. "The Ambulatory Medical Assistance (AMA) programme during active‐phase treatment in patients with haematological malignancies: A cost‐effectiveness analysis," Post-Print hal-03889400, HAL.
    • Handle: RePEc:hal:journl:hal-03889400
    DOI: 10.1111/ecc.13709
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-03889400. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.